Terms: = Colorectal cancer AND ACSL6, FACL6, 23305, ENSG00000164398, KIAA0837, LACS5, ACS2, LACS2 AND Prognosis
4 results:
1. ACSL family: The regulatory mechanisms and therapeutic implications in cancer.
Quan J; Bode AM; Luo X
Eur J Pharmacol; 2021 Oct; 909():174397. PubMed ID: 34332918
[TBL] [Abstract] [Full Text] [Related]
2. Integrated Analysis of miRNA and mRNA Endorses a Twenty miRNAs Signature for colorectal Carcinoma.
Angius A; Uva P; Pira G; Muroni MR; Sotgiu G; Saderi L; Uleri E; Caocci M; Ibba G; Cesaraccio MR; Serra C; Carru C; Manca A; Sanges F; Porcu A; Dolei A; Scanu AM; Rocca PC; De Miglio MR
Int J Mol Sci; 2019 Aug; 20(16):. PubMed ID: 31434359
[TBL] [Abstract] [Full Text] [Related]
3. Identification of Critical Genes and Five Prognostic Biomarkers Associated with colorectal cancer.
Huang Z; Yang Q; Huang Z
Med Sci Monit; 2018 Jul; 24():4625-4633. PubMed ID: 29973580
[TBL] [Abstract] [Full Text] [Related]
4. Systematic Analysis of Gene Expression Alterations and Clinical Outcomes for Long-Chain Acyl-Coenzyme A Synthetase Family in cancer.
Chen WC; Wang CY; Hung YH; Weng TY; Yen MC; Lai MD
PLoS One; 2016; 11(5):e0155660. PubMed ID: 27171439
[TBL] [Abstract] [Full Text] [Related]
